Status:
UNKNOWN
Rehabilitation With HHFNC in COPD in Nocturnal NIV
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Humidified High Flow Nasal Cannula (HHFNC), with optional supplemental oxygen delivery, has evolved in recent years with an increasing number of papers that show a better meet with respiratory demand,...
Detailed Description
RECRUITMENT PHASE: A qualified physiotherapist will check patient lists daily with the aim of identifying suitable candidates for the study. The patients will be enrolled from January 2020 till june ...
Eligibility Criteria
Inclusion
- Diagnosis of Chronic Obstructive Pulmonary Disease (post-bronchodilator Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) \<0.7) ;
- Nocturnal Non Invasive Ventilation (NIV) prescription according to ATS/ERS guidelines with or without long-term oxygen therapy;
- Clinical stability (no exacerbation and no changing in respiratory drugs in the last 7 days);
Exclusion
- Orthopedic or neurological pathologies that limit physical performance;
- Cognitive impairment (Mini-Mental State Examination \<24);
- Advanced heart disease, pulmonary fibrosis, participation in other clinical studies in the six months preceding the start of the study.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04683952
Start Date
January 1 2020
End Date
January 1 2022
Last Update
December 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi
Milan, Italy, 20148